Volume 22, Issue 2 - Medical Writing Around the World

The yin and yang of medical writing in China

Authors: Karen L. Woolley, Ping Sun

Abstract

Download the full article

References

1. Statement from Xi Jinping (15 November 2012). [accessed 2012 Dec 17]. Available from: http://www.bbc.co.uk/news/world-asia-china-20338586
2. Peng C. Focus on quality, not just quantity. Nature 2011;475:267.
3. Gonzales C, Liu Y, Shu X. The faculty promotion and merit system in China and the United States: the cases of Wuhan University and the University of California, Davis. CSHE Research & Occasional Paper Series. 2012;1–11. Available from: http://cshe.berkeley.edu/publications/docs/ROPS.Gonzalez%20et%20al.Faculty%20Promotion.10.1.2012.pdf
4. Walker RL, Sykes L, Hemmelgarn B, Quan H. Authors’ opinions on publication in relation to annual performance assessment. BMC Med Educ 2010;10:21–6.
5. Sun P. China's efforts for promoting research integrity. Prof Ethics Rep 2010;23(4):1–3.
6. Liu XY, Wan XH, Li ZW. Ten-year survey on oncology publications from China and other top-ranking countries. Chin Med J 2011;124(20):3314–19.
7. Woolley KL. Ethical medical writing practices – every document, every time, every country! 3rd DIA China Annual Meeting; 2011 May 15; Beijing.
8. Woolley KL. Ethical medical writing practices – every document, every time, every country! 4th DIA China Annual Meeting; 2012 May 20; Shanghai.
9. Ma B, Ke FY, Chen ZM, Qi GQ, Li HM, Liu WJ, et al. Does the reporting of randomized clinical trials published in Chinese pediatrics journals improve after the CONSORT Statement is adopted? Contemp Clin Trials 2012;33(5):889–94.
10. Purgato M, Cipriani A, Barbui C. Randomized trials published in Chinese or Western journals: comparative empirical analysis. J Clin Psychopharmacol 2012;32(3):354–61.
11. Chen Y, Li J, Ai C, Duan Y, Wang L, Zhang M, et al. Assessment of the quality of reporting in abstracts of randomized controlled trials published in five leading Chinese medical journals. PLoS One 2010;5(8):e11926.
12. Wang L, Li Y, Li J, Zhang M, Xu L, Yuan W, et al. Quality of reporting of trial abstracts needs to be improved: using the CONSORT for abstracts to assess the four leading Chinese medical journals of traditional Chinese medicine. Trials 2010;11:75.
13. Duan Y, Li J, Ai C, Chen Y, Chen P, Zhang M, et al. Quality of trials reported as conference abstracts in China: how well are they reported? Int J Technol Assess Health Care 2009;25(4):479–84.
14. Li XQ, Tao KM, Zhou QH, Moher D, Chen HY, Wang FZ, et al. Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of instructions for authors and published papers. PLoS One 2012;7(2):e30683.
15. Bian Z, Liu B, Moher D, Wu T, Li Y, Shang H, et al. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Front Med 2011;5(2):171–77.
16. Ma B, Guo J, Qi G, Li H, Peng J, Zhang Y, et al. Epidemiology, quality and reporting characteristics of systematic reviews of traditional Chinese medicine interventions published in Chinese journals. PLoS One 2011;6(5):e20185.
17. Woolley KL. Goodbye ghostwriters!: how to work ethically and efficiently with professional medical writers. Chest 2006;130(3):921–3 [Article also available in Chinese and Japanese].
18. Woolley KL, Gertel A, Hamilton C, Jacobs A, Snyder G, Global Alliance of Publication Professionals. Don't be a fool – don't use fool's gold. Am J Med 2012;125(10):e21–2.
19. Ely JA, Lew RA, Woolley KL. Importance of cultural sensitivity when medical writers work with authors from the Asia-Pacific region. DIA Global Forum 2010;21(4):20–5.
20. Woolley KL, Wang M, Matheis R. Rebuilding trust in medical journal publications. DIA Global Forum 2011;3(6):24–7.
21. Woolley KL, Gertel A, Hamilton C, Jacobs A, Snyder G, Global Alliance of Publication Professionals. Poor compliance with reporting research results – we know it's a problem … how do we fix it? Curr Med Res Opin 2012;28(11):1857–60.
22. Bailey M. Science editing and its effect on manuscript acceptance time. AMWA J 2011;26(4):147–52.
23. Jacobs A. Adherence to the CONSORT guideline in papers written by professional medical writers. Write Stuff 2010;19(3):196–200.
24. Graf C, Battisti WP, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, et al. Research methods & reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330.
25. Woolley KL, Lew RA, Stretton S, Ely JA, Bramich N, Keys JR, et al. Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study. Curr Med Res Opin 2011;27(6):1175–82.
26. Stretton S, Bramich NJ, Keys JR, Monk JA, Ely JA, Haley C, et al. Publication misconduct and plagiarism retractions: a systematic, retrospective study. Curr Med Res Opin 2012;28(10):1575–83.
27. Ito S, Rathaur M, Tabata Y, Albani C. Trends in Asia clinical outsourcing. PRTM Report; 2010 [accessed 2012 December 17]. Available from: http://www.prtm.com/uploadedFiles/Strategic_Viewpoint/Articles/Article_Content/PRTM_Asia_Clinical_Outsourcing.pdf?n=9722